Holen Sie sich die Stockscreener-App
8.94
3.83%
0.33
Schlusskurs vom Vortag:
$8.61
Offen:
$8.69
24-Stunden-Volumen:
521.07K
Relative Volume:
0.93
Marktkapitalisierung:
$561.14M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
-2.19%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$8.50
$9.80
52-Wochen-Spanne:
$8.50
$15.50
Electra Therapeutics, Inc. Common stock Stock (ETRA) Company Profile
Firmenname
Electra Therapeutics, Inc. Common stock
Sektor
Branche
Telefon
-
Adresse
-
Compare ETRA vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ETRA
Electra Therapeutics, Inc. Common stock
|
8.94 | 561.14M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
498.50 | 126.35B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
226.30 | 90.35B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
778.36 | 80.14B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
818.30 | 51.46B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
193.52 | 41.48B | 742.00K | -1.37B | -1.07B | -7.0731 |
Electra Therapeutics, Inc. Common stock Stock (ETRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2026-10-13 | Eingeleitet | Evercore ISI | Outperform |
| 2026-10-13 | Eingeleitet | Jefferies | Buy |
| 2026-10-13 | Eingeleitet | TD Cowen | Buy |
Electra Therapeutics, Inc. Common stock Aktie (ETRA) Neueste Nachrichten
Two entities report shared voting power over more than 5% of Electra Therapeutics (ETRA). - Stock Titan
An investment manager reports a stake above 5% in Electra Therapeutics (ETRA) after its IPO. - Stock Titan
OrbiMed Advisors Discloses Investment at Electra Therapeutics with 11.0% Stake - TradingView
Two funds bought Electra Therapeutics (ETRA) IPO shares at $15. OrbiMed reports their stake. - Stock Titan
Total common shares outstanding of Electra Therapeutics, Inc. – NASDAQ:ETRA - TradingView
Form 4 Electra Therapeutics For: 23 September By Investing.com - Investing.com Nigeria
ETRA SEC Filings, Sep 18, 2026Electra Therapeutics, Inc. Filing Archive - stocktitan.net
Form 4 Electra Therapeutics For: 23 September By Investing.com - Investing.com South Africa
A $15 IPO brought share purchases and preferred-stock conversions at Electra Therapeutics (ETRA). - Stock Titan
At $15 a share, OrbiMed funds bought Electra Therapeutics (ETRA) stock as preferred shares converted. - Stock Titan
Total common shares outstanding of Electra Therapeutics, Inc. – BOATS:ETRA - TradingView
Electra Therapeutics, Inc. Statistics – NASDAQ:ETRA - TradingView
OrbiMed Discloses Preferred Stock Conversion and Significant IPO Share Acquisitions in Electra Therapeutics - Kalkine Media
[Form 4] Electra Therapeutics, Inc. Insider Trading Activity - Stock Titan
Electra Therapeutics (ETRA) director converts 255K preferred in IPO - Stock Titan
Electra Therapeutics (ETRA) CEO converts preferred stake into 455,484 common shares tied to IPO - Stock Titan
Electra Therapeutics (ETRA) Stock Price, News & Analysis - Stock Titan
[Form 4] Electra Therapeutics, Inc. Insider Trading Activity - stocktitan.net
Electra Therapeutics, Inc. Common stock (ETRA) stock price, news, quote and history - Yahoo Finance Australia
Kinzey Capital Management: Electra Sets Nasdaq IPO Terms - GlobeNewswire Inc.
ETRA SEC Filings, Sep 18, 2026Electra Therapeutics, Inc. Filing Archive - Stock Titan
Electra Therapeutics (ETRA) CFO reveals 612K options running to 2036 - Stock Titan
Electra Therapeutics (ETRA) details 2036 option grants for accounting chief - Stock Titan
Electra Therapeutics (ETRA) director details three long-term option grants - Stock Titan
Parry Graham discloses two stock option holdings at Electra Therapeutics (ETRA) - Stock Titan
[Form 3] Electra Therapeutics, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Electra CEO’s option and preferred stake (ETRA) - Stock Titan
Electra Therapeutics (ETRA) CSO discloses stock options and IPO-convertible preferred shares - Stock Titan
OrbiMed funds’ Electra Therapeutics (ETRA) preferred holdings and a director option detailed - Stock Titan
ETRA SEC FilingsElectra Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Electra Therapeutics (ETRA) pursues IPO as auditor raises going-concern warning - Stock Titan
Latham & Watkins Advises on Electra Therapeutics’ Upsized US$350 Million Initial Public Offering - Latham & Watkins LLP
Electra Therapeutics, Inc. Common stock (ETRA) stock price, news, quote and history - Yahoo Finance UK
Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering - GlobeNewswire
Dear Future Electra Therapeutics Stock Fans, Mark Your Calendars for Sept. 18 - Yahoo Finance
Electra amasses $350M in biotech’s latest big IPO - BioPharma Dive
Electra Therapeutics Files for US IPO - Yahoo Finance
Electra Therapeutics files for IPO to fund immune disease drugs By Investing.com - Investing.com India
Electra Therapeutics files for IPO to fund immune disease drugs - Investing.com
Finanzdaten der Electra Therapeutics, Inc. Common stock-Aktie (ETRA)
Es liegen keine Finanzdaten für Electra Therapeutics, Inc. Common stock (ETRA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Electra Therapeutics, Inc. Common stock-Aktie (ETRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Director |
Sep 21 '26 |
Buy |
15.00 |
1,333,333 |
19,999,995 |
5,126,891 |
6.10%
5.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):